SKIN Historical PE Ratio image   This SKIN PE ratio history page last updated 11/10/2022
SKIN PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/8/2022
10.700.05-0.11NA
Q2 2022
8/9/2022
12.800.01-1.79NA
Q1 2022
5/10/2022
12.50-0.06-3.33NA
Q4 2021
2/22/2022
12.84-0.12-3.30NA
Q3 2021
11/9/2021
28.67-1.63NANA
Q2 2021
8/10/2021
18.75-1.52NANA
Q1 2021
5/13/2021
12.15-0.03NANA
SKIN Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/8/2022
10.700.050.2053.5
Q2 2022
8/9/2022
12.800.010.06228.6
Q1 2022
5/10/2022
12.50-0.06-0.22NA
Q4 2021
2/22/2022
12.84-0.12-0.48NA
Q3 2021
11/9/2021
28.67-1.63-6.52NA
Q2 2021
8/10/2021
18.75-1.52-6.08NA
Q1 2021
5/13/2021
12.15-0.03-0.12NA
Quotes delayed 20 minutes

Email EnvelopeFree SKIN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
The Beauty Health Company - Class A Common Stock (SKIN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SLDB PE Ratio History
SLNO PE Ratio History
SLRX PE Ratio History
SLS PE Ratio History
SMLR PE Ratio History
SMMT PE Ratio History
SMTI PE Ratio History
SNDA PE Ratio History
SNDX PE Ratio History
SNGX PE Ratio History
On this page we presented the SKIN PE Ratio History information for The Beauty Health Company - Class A Common Stock' stock. The average SKIN PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 141.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SKIN PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SKIN PE ratio history result, against the recent PE: when this page was posted on 11/9/2022, the most recent closing price for SKIN had been 8.44, and the most recent quarterly earnings result, annualized, was 0.2. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent SKIN PE on 11/9/2022 based on annualized quarterly EPS was 42.2. Based on SKIN's history, that recent PE is low relative to the historical average, with the recent PE 70.1% lower than the historical average PE across our data set for The Beauty Health Company - Class A Common Stock.

For self directed investors doing their due diligence on SKIN or any other given stock, valuation analysis for SKIN can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate The Beauty Health Company - Class A Common Stock PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for SKIN. Thanks for visiting, and the next time you need to research SKIN PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: MUH Videos, Funds Holding CMTL, PROV market cap history.

 

SKIN PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.